Nom du produit:trans-tert-Butyl 3-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate
IUPAC Name:tert-butyl (3S,4S)-3-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate
- CAS:219975-81-2
- Formule moléculaire:C11H21NO4
- Pureté:98%
- Numéro de catalogue:CM514919
- Poids moléculaire:231.29
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:219975-81-2
- Formule moléculaire:C11H21NO4
- Point de fusion:-
- Code SMILES:O=C(N1C[C@@H](O)[C@H](CO)CC1)OC(C)(C)C
- Densité:
- Numéro de catalogue:CM514919
- Poids moléculaire:231.29
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Piperidines
- Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
- Piperidine,Piperidine Price
- if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Column Infos
- Samuraciclib
- Carrick Therapeutics’ Phase 2 Clinical Trial of Samuraciclib combined with Fulvestrant has dosed its first patient. The study targets patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer. Samuraciclib is a selective oral, first-in-class inhibitor of CDK7. It is involved in the regulation of cancer-causing genes, promotion of uncontrolled cell cycle progression, and increase in resistance to anti-hormone therapy. The comb previously receives the Fast Track Designation from the U.S. FDA.